Rise In Investment In The Bioinformatics Is Leading To Expansion Of The Computational Biology Market
Computational biology is one of the most rapidly advancing areas in all of biology. It combines principles from genomics, cellular biology, computer science, information science, and medicine and it contributes to advances in many areas of biology. Computational Biology includes the study and research of complex biological systems, the design and manipulation of complex systems, the analysis and measurement of complex biological functions, and the applications to these systems of various scientific disciplines. Computational Biology is the fastest growing area of scientific research and has a significant impact on advances in all areas of biology and medical research. Computational Biology employs techniques from physics, computer science, mathematics, and software engineering to study living things and systems at various scales from the single-cell up to human organs and muscles.
North
America is estimated to exhibit significant growth in the global computational biology market and this is accredited to the rise in the funding on research
organization especially in the United States. For example, The U.S. National
Science Foundation accounts for about 25% of federal support to academic
institutions for research in the fields of science and engineering. It provides
grants and cooperative agreements to more than 2,000 colleges, universities,
K-12 school systems, businesses, informal science organizations, and other
research organizations in the United States.
Key
factors driving the growth of the computational biology market are the rise in
demand for predictive models, increasing application in human genome projects,
and growing R &D for drug discovery. A growing number of clinical studies
in pharmacogenomics and pharmacokinetics and growth in bioinformatics research
has also augmented the growth of the computational biology market. The rise in
research funding in bioinformatics is leading to more advancement in the field
of computational biology. For instance, The National Institutes of Health is
the largest public funder of biomedical research in the world, with 24
institutes and centers awarding $32 billion a year in grants to improve human
life and reduce illness and disability.
Key Developments:
1. In May 2020, Evogene Ltd. a
computational biology company targeting to revolutionize life-science product
development across several market segments, announces it's rebranding
2. In March 2021, ALSA Ventures
announced the launch of Promatix Inc., a Delaware incorporated company, to
develop novel therapeutics with the potential to transform the treatment of
cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine
for a novel, and validate existing, drug targets.
Comments
Post a Comment